© Rosalind Scientific LLC 2018-2022
© Rosalind Scientific LLC, 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >3,500 drug hunters worldwide, unsubscribe anytime.
<< Back to February
selective TLR7/8 inhibitor (dimer stabilizer)
in Ph. I for lupus (oral twice-daily)
from screening for TLR7/8-selective agents
J. Pharmacol. Exp. Ther., Mar. 1, 2021
EMD Serono/Merck KGaA, Billerica, MA
11. The EMD Serono/Merck KGaA toll-like receptors TLR7/TLR8 inhibitor M5049 is an oral, twice-daily anti-inflammatory agent currently in a Ph. I trial for Lupus. The molecule potently blocks both…
Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.